Latest Racing News

Wia Gold Limited has significantly upgraded its Kokoseb Gold Project resource to 2.93 million ounces, advancing steadily toward a Definitive Feasibility Study targeted for late 2026. The company’s accelerated drilling and strong high-grade results underpin its ambition to become Namibia’s fourth commercial gold mine.

Archer Materials advances its quantum computing and medical diagnostics technologies, extending key partnerships and forming a new advisory board while maintaining a strong cash position to fuel development.

Proteomics International’s subsidiary OxiDx has unveiled a pioneering test that detects muscle damage in thoroughbred racehorses, promising to transform recovery management in the racing industry. The test’s commercial launch is slated for the second half of 2025.

Race Oncology has secured key ethics approvals to launch its Phase 1 RC220 trial at two major Hong Kong hospitals, marking a strategic expansion beyond Australia to accelerate patient recruitment and explore cardioprotective benefits.

Belararox Limited is set to begin drilling four priority copper targets in its Kalahari Copper Project this August, following extensive geological and geophysical surveys. The move marks a significant step forward in exploring a highly prospective region of the Kalahari Copper Belt.

Sports Entertainment Group (SEG) is set to become the sole broadcaster of all three Victorian racing codes after agreeing to acquire RSN’s brand and broadcasting assets for $3.25 million.

BlinkLab has expanded its pivotal FDA autism diagnostic trial by adding the University of Nebraska Medical Center as a second U.S. clinical site, advancing toward broader validation and regulatory clearance.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

MIXI Australia has secured crucial gaming approvals from Ontario regulators, removing a major obstacle in its proposed takeover of PointsBet Holdings. The bid now awaits shareholder acceptance to proceed.

Imugene Limited has received a $5.87 million R&D tax refund, reinforcing its capacity to advance clinical trials in immuno-oncology. This funding milestone supports the development of its innovative cancer therapies, including CAR T cell treatments and oncolytic virotherapy.

Battery Age Minerals has initiated its first diamond drilling campaign at the Bleiberg Zinc-Lead-Germanium Project in Austria, aiming to unlock high-grade critical minerals essential for advanced technologies and European supply security.

Gold Hydrogen has attracted a $14.5 million strategic investment from global energy leaders Toyota, Mitsubishi Gas Chemical, and ENEOS Xplora, following promising drilling results in South Australia. The funds will accelerate exploration and commercialisation of natural hydrogen and helium resources.